Long term effects of COVID-19 in people with diabetes

Longer term impact of COVID infection in people with diabetes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN14643181

Enrollment

1000

Registered

2021-05-24

Start date

2021-05-28

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) in people with diabetes Infections and Infestations COVID-19 (SARS-CoV-2 infection)

Interventions

Observational study with current health measured by questionnaire, bioimpedance, pulmonary function, grip strength, walking test. 1. Case cohort study - conducted with questionnaire u

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: People aged over 18 resident in Scotland and with prior diagnosis of type 1 or type 2 diabetes

Exclusion criteria

Exclusion criteria: Not able to read and write in English

Design outcomes

Primary

Measure	Time frame
COVID symptoms measured using Wellcome Trust COVID-19 questionnaire at baseline (all participants) and 1 year (cases only)	—

Secondary

Measure	Time frame
Measured at baseline (all participants in case cohort study) and 1 year (cases in case cohort study only) 1. Bioimpedance measured using bioelectrical impedance analysis 2. Pulmonary function measured using lung function test 3. Grip strength measured using dynamometer 4. Physical ability measured using walking test 5. Diabetes Related Quality of Life (DQOL) 6. Diabetes-Specific Emotional Distress (DDS-1) 7. Quality of life (EQ5D) 8. HbA1c, LFTs, lipids, U&Es, inflammatory (e.g. CRP), vascular (t-PA, vWF) and cardiac (hs troponin, NT proBNP) biomarkers measured using blood test	—

Measure

Time frame

Measured at baseline (all participants in case cohort study) and 1 year (cases in case cohort study only) 1. Bioimpedance measured using bioelectrical impedance analysis 2. Pulmonary function measured using lung function test 3. Grip strength measured using dynamometer 4. Physical ability measured using walking test 5. Diabetes Related Quality of Life (DQOL) 6. Diabetes-Specific Emotional Distress (DDS-1) 7. Quality of life (EQ5D) 8. HbA1c, LFTs, lipids, U&Es, inflammatory (e.g. CRP), vascular (t-PA, vWF) and cardiac (hs troponin, NT proBNP) biomarkers measured using blood test

—

Countries

Scotland, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026